U.S. Auto Stock News

Murphy USA (MUSA) just posted a strong first quarter update, with revenue of US$4,819.3 million and net income of US$136.3 million, as fuel and merchandise margins and capital returns supported investor interest. See our latest analysis for Murphy USA. The earnings beat and store expansion plans have come alongside a sharp 36.33% 3 month share price return and a 46.25% year to date share price return, while the 5 year total shareholder return of 325.18% reflects a strong longer term payoff...

Deere & Company recently appointed T. Brent Norwood, 44, as senior vice president and chief financial officer, effective May 1, 2026, following an internal and external search that emphasized his two decades of experience with the company and in the broader financial industry. Norwood’s background in major acquisitions, precision-focused initiatives like the Smart Industrial strategy and Leap Ambitions, and investor relations recognition suggests he could influence how Deere balances growth...

Stock performance context and business mix LCI Industries (LCII) has drawn attention after a period of share price weakness, with the stock showing negative returns over the past week, month and past 3 months, despite a positive 1 year total return. At a recent close of $106.79 and a market value of about $2.8b, the company sits at the intersection of recreational vehicles and broader transportation. It supplies components across both original equipment manufacturers and aftermarket...

Symbotic (SYM) is back in focus after unveiling its next generation storage structure and reporting a single day record of more than 6.5 million cases processed, developments that are drawing fresh attention to the stock. See our latest analysis for Symbotic. Despite the upbeat operational news, the stock has cooled recently. The 1 month share price return is 6.8%, but the year to date share price return reflects a 12.1% decline, while the 1 year total shareholder return is 148.5%, suggesting...

Why Addus HomeCare Stock Is On Investors’ Radar Addus HomeCare (ADUS) has drawn attention after recent trading leaves the stock with a market value of about US$1.8b and a latest closing price of US$100.12 per share. With year-to-date and 1-year total returns both in negative territory, yet a 3-year total return close to 20%, investors are weighing how the company’s current valuation lines up with its financial profile. See our latest analysis for Addus HomeCare. The recent 9.31% 1 month share...

Recent trading performance and business mix Baldwin Insurance Group (BWIN) has been under pressure, with the stock showing a 46.0% negative total return over the past year and a 7.6% decline year to date, despite a 7.2% gain in the past 3 months. At a last close of US$21.97 and a market value of about US$3.2b, the company operates as an independent insurance distribution platform in the United States, spanning advisory, underwriting and mainstreet-focused solutions. See our latest analysis...

DiDi Global stock performance snapshot DiDi Global (OTCPK:DIDI.Y) has drawn fresh attention after recent trading, with the stock last closing at US$3.66. That price sits alongside a market value of about US$16.2b for the Beijing based ride hailing platform. See our latest analysis for DiDi Global. For context, DiDi Global’s share price return is down 21.2% over the past 90 days and 34.3% year to date, while the 3 year total shareholder return is slightly positive. This suggests that recent...

Recent TV attention on MP Materials (MP), including repeated supportive comments from Jim Cramer, has converged with fresh U.S. government backing and a planned Texas magnet facility that highlights the company’s role in the rare earth industry. See our latest analysis for MP Materials. Those headlines have coincided with a strong run in MP Materials' share price, with a 30 day share price return of 33.12% and a year to date share price return of 20.43%. Total shareholder return sits at...

FinVolution Group has released its FY25 results, showing revenue and operating income declines amid regulatory and credit pressures in its core market, while its international operations grew to about 25% of total revenue and delivered around US$15 million in profit. An interesting angle is that, despite higher underwriting and customer acquisition costs abroad, the international segment’s profitability and clearer disclosure around 2025 regulatory impacts contributed to a rating upgrade to...

The latest move in JFrog (FROG) came as investors responded to renewed optimism across software stocks, after strong earnings and upbeat forecasts from enterprise peers such as Atlassian and Twilio lifted sector sentiment. See our latest analysis for JFrog. At a share price of US$52.58, JFrog has seen short term momentum pick up, with a 1 day share price return of 5.39% and a 7 day share price return of 13.86%. The 1 year total shareholder return of 52.85% and 3 year total shareholder return...

CNA Financial Corporation has already reported first-quarter 2026 results, with revenue of US$3,677 million and net income of US$211 million, as weaker underwriting and unfavorable reserve development weighed on earnings per share of US$0.78. Despite the softer profitability and a higher combined ratio in its Property & Casualty business, the board maintained a regular quarterly dividend of US$0.48 per share, signaling continued confidence in the company’s capital position. We’ll now...

Omnicom Group stock snapshot Omnicom Group (OMC) has recently drawn investor attention after a period of mixed share performance, with the stock showing a month gain alongside a negative year to date return and modest 1 year total return. At a recent close of US$76.27, Omnicom Group sits against a backdrop of global operations in advertising, marketing, and corporate communications, serving clients across North America, Europe, the Asia Pacific, Latin America, and the Middle East and...

Revolution Medicines (RVMD) is back in focus after the FDA cleared expanded access to its investigational drug daraxonrasib for certain metastatic pancreatic cancer patients, following Phase 3 data showing improvements in overall survival and progression-free survival. See our latest analysis for Revolution Medicines. The stock’s recent move appears closely linked to the daraxonrasib news flow, with a 1 day share price return of 6.04% and a 30 day share price return of 49.21% contributing to...

Old National Bancorp (ONB) drew investor attention after reporting first quarter net interest income of US$572.57 million and net income of US$233.67 million, along with US$32 million in net charge offs and updated share repurchase activity. See our latest analysis for Old National Bancorp. The first quarter update, including higher reported net interest income and net income alongside US$32 million of net charge offs and recent buyback activity, comes as the share price sits at US$23.78 with...

In early May 2026, WEX Inc. and activist investor Impactive Capital reached a cooperation agreement that ended their proxy contest, added three Impactive-backed nominees to an expanded 11-member board, and committed WEX to separating its Chair and CEO roles after the upcoming annual meeting. This governance reset, arriving after months of public debate and proxy advisor scrutiny, signals a meaningful shift in how shareholder influence will shape WEX’s oversight and long-term decisions...

Earnings jump draws fresh focus to Equitable Holdings stock Equitable Holdings (EQH) just posted first quarter results that show net income of US$621 million compared with US$63 million a year earlier, while revenue for the quarter was US$4.23 billion versus US$4.58 billion. See our latest analysis for Equitable Holdings. At a share price of US$41.49, Equitable Holdings has a 30 day share price return of 9.79%, while its 1 year total shareholder return of 15.58% decline contrasts with an...

Capricor Therapeutics (CAPR) stock is in focus after the company presented Phase 3 HOPE 3 data for Deramiocel in Duchenne muscular dystrophy at the American Academy of Neurology 2026 Annual Meeting. See our latest analysis for Capricor Therapeutics. That update comes after a sharp move in Capricor Therapeutics stock, with a 1-day share price return of 8.38% and a 90-day share price return of 34.65%, alongside a very large 1-year total shareholder return that sits in the mid single digit...

Pediatrix Medical Group, Inc. has reported past first-quarter 2026 results showing sales of US$476.2 million and net income of US$29.57 million, with diluted earnings per share from continuing operations of US$0.36, all higher than the same period a year earlier. The company’s better-than-expected performance, driven by stronger same-unit revenue and improved cash collections, came alongside a reaffirmed full-year adjusted EBITDA outlook that supports management’s operational and financial...

Amylyx Pharmaceuticals stock in focus Amylyx Pharmaceuticals (AMLX) has drawn investor attention after recent trading, with the stock closing at US$16.46 and a market value of about US$1.78b, backed by a clinical stage pipeline in neurodegenerative and endocrine conditions. See our latest analysis for Amylyx Pharmaceuticals. The recent 2.81% 1 day share price return and 10.10% 30 day share price return sit alongside a 44.13% year to date share price return. The 1 year total shareholder return...

In April 2026, Rocket Lab Corporation launched its second dedicated mission for Japan’s space agency JAXA and unveiled a new High-Performance Star Tracker designed for long-duration, radiation-intensive spacecraft missions, extending its vertically integrated space systems portfolio. The combination of deeper collaboration with JAXA and an upgraded, radiation-hardened star tracker strengthens Rocket Lab’s role as both a launch provider and a growing space hardware supplier. We’ll now examine...

Why Applied Materials stock is on investors’ radar today Applied Materials (AMAT) is drawing attention after a strong long term performance profile, highlighted by a total return of about 155% over the past year and roughly 247% over three years. See our latest analysis for Applied Materials. At a latest share price of $391.38, Applied Materials has seen a 12.31% 1 month share price return and 22.82% 3 month share price return, while its 1 year total shareholder return of 155.40% underlines...

Moderna (MRNA) is back in focus after first quarter 2026 results, with revenue of US$389 million, a GAAP net loss of US$1.343b, new EU vaccine approvals, and progress in its oncology pipeline. See our latest analysis for Moderna. Moderna's share price has been volatile around the latest results, with a 1-day share price return of 4.25% but a 7-day return of 2.87%. A 90-day gain of 12.09% and year to date share price return of 53.27% contrast with a 3-year total shareholder return of 64.10%...

Q1 earnings and buyback completion put Mueller Industries in focus Mueller Industries (MLI) is back on investors’ radar after first quarter 2026 results showed higher sales, net income, and earnings per share compared with a year earlier, alongside the completion of a long running share repurchase program. See our latest analysis for Mueller Industries. The earnings beat and completion of a long running buyback have come after a 1 month share price return of 18.18% and a 1 year total...

Patrick Industries stock performance snapshot Patrick Industries (PATK) has drawn investor attention after recent trading left the stock at US$85.13, with returns of about 4% over the past year and a little more than 100% over the past 3 years. See our latest analysis for Patrick Industries. Despite the recent pullback, with a 30 day share price return of a 26% decline and a 90 day share price return of a 36% decline, Patrick Industries still shows longer term momentum through a 3 year total...